Tau-Centric Targets and Drugs in Clinical Development for the Treatment of Alzheimer’s Disease
Tau-Centric Targets and Drugs in Clinical Development for the Treatment of Alzheimer’s Disease
About this item
Full title
Author / Creator
Publisher
Cairo, Egypt: Hindawi Publishing Corporation
Journal title
Language
English
Formats
Publication information
Publisher
Cairo, Egypt: Hindawi Publishing Corporation
Subjects
More information
Scope and Contents
Contents
The failure of several Phase II/III clinical trials in Alzheimer’s disease (AD) with drugs targeting β-amyloid accumulation in the brain fuelled an increasing interest in alternative treatments against tau pathology, including approaches targeting tau phosphatases/kinases, active and passive immunization, and anti-tau aggregation. The most advanced...
Alternative Titles
Full title
Tau-Centric Targets and Drugs in Clinical Development for the Treatment of Alzheimer’s Disease
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4939203
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4939203
Other Identifiers
ISSN
2314-6133
E-ISSN
2314-6141
DOI
10.1155/2016/3245935
